Evidence map›Paper›PMID 33096917›Full record

ArticlePharmaceuticals (Basel, Switzerland)2020

Reversal of Ovarian Cancer Cell Lines Multidrug Resistance Phenotype by the Association of Apiole with Chemotherapies.

Carolina Afonso de Lima, Ian Lucas de Souza Bueno, Stanley Nunes Siqueira Vasconcelos, Juliana Mozer Sciani, Ana Lúcia Tasca Gois Ruiz, Mary Ann Foglio, João Ernesto de Carvalho, Giovanna Barbarini Longato

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Carolina Afonso de LimaResearch Laboratory in Molecular Pharmacology and Bioactive Compounds, São Francisco University, Bragança Paulista, São Paulo 12916-900, Brazil.
Ian Lucas de Souza BuenoResearch Laboratory in Molecular Pharmacology and Bioactive Compounds, São Francisco University, Bragança Paulista, São Paulo 12916-900, Brazil.
Stanley Nunes Siqueira VasconcelosCenter for Medicinal Chemistry (CQMED), University of Campinas (UNICAMP), Campinas, São Paulo 13083-875, Brazil.ORCID 0000-0001-7289-5753
Juliana Mozer ScianiLaboratory of Multidisciplinary Research, São Francisco University, Bragança Paulista, São Paulo 12916-900, Brazil.ORCID 0000-0001-7213-206X
Ana Lúcia Tasca Gois RuizLAFTEx Faculty of Pharmaceutical Science, University of Campinas, Campinas, São Paulo 13083-859, Brazil.ORCID 0000-0002-0844-8702
Mary Ann FoglioLAFTEx Faculty of Pharmaceutical Science, University of Campinas, Campinas, São Paulo 13083-859, Brazil.
João Ernesto de CarvalhoLAFTEx Faculty of Pharmaceutical Science, University of Campinas, Campinas, São Paulo 13083-859, Brazil.
Giovanna Barbarini LongatoResearch Laboratory in Molecular Pharmacology and Bioactive Compounds, São Francisco University, Bragança Paulista, São Paulo 12916-900, Brazil.ORCID 0000-0001-5828-8957
Universidade Estadual de Campinas (UNICAMP) · BRUniversidade São Francisco · BR

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2010/50232-7Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/06137-6Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/09475-5
6 · The paper itself

Abstract

Multidrug resistance (MDR) is the main obstacle in anticancer therapy. The use of drug combinations to circumvent tumor resistance is a well-established principle in the clinic. Among the therapeutic targets, glycoprotein-P (P-gp), an energy-dependent transmembrane efflux pump responsible for modulating MDR, is highlighted. Many pharmacological studies report the ability of calcium channel blockers to reverse tumor resistance to chemotherapy drugs. Isolated for the first time from parsley, the phenylpropanoid apiole is described as a potent calcium channel inhibitor. Taking this into account, herein, the ability of apiole to potentiate the action of well-established chemotherapeutics in the clinic, as well as the compound's relationship with the reversal of the resistance phenomenon by blocking P-gp, is reported. The association of apiole with both chemotherapeutic drugs doxorubicin and vincristine resulted in synergistic effect, in a concentration-dependent manner, as evaluated by the concentration reduction index. Molecular docking analysis demonstrated the affinity between apiole and the active site of P-gp, corroborating the inhibitory effect. Moreover, apiole demonstrated druglikeness, according to ADME analysis. In conclusion, apiole possibly blocks the active P-gp site, with strong binding energy, which, in turn, inhibits doxorubicin and vincristine efflux, increasing the antiproliferative response of these chemotherapeutic agents.

Indexed as

apioledruglikenessglycoprotein-Pin silicomultidrug resistance

Identifiers

PMID33096917
PMCPMC7589691
OpenAlexW3094572491

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.